Johnson & Johnson Announces Participation in 2026 RBC Capital Markets Global Healthcare Conference

Johnson & Johnson will participate in the 2026 RBC Capital Markets Global Healthcare Conference on Tuesday, May 19th, as confirmed by the company’s announcement on April 21, 2026. The healthcare conglomerate will send members of its management team to the event, which is part of RBC Capital Markets’ annual series of industry conferences.

The announcement was made through Johnson & Johnson’s official media channels on April 21, 2026, aligning with the company’s routine participation in major investor conferences throughout the year. This year’s event marks another instance of the New Brunswick-based pharmaceutical and medical devices company engaging directly with investors and analysts through RBC Capital Markets’ platform.

According to RBC Capital Markets’ published conference schedule, the Global Healthcare Conference is set to take place over two days, May 19-20, in New York City. The event is described as a gathering of industry leaders, innovators, and investors focused on discussing emerging trends and opportunities within the healthcare sector.

Johnson & Johnson’s participation follows a pattern of regular attendance at similar healthcare-focused investor conferences. The company previously participated in the 2025 edition of the RBC Capital Markets Global Healthcare Conference, which was held on Tuesday, May 20th, 2025, as documented in the company’s press release from April 16, 2025.

The Bank of America 2026 Healthcare Conference is also listed in Johnson & Johnson’s upcoming events, with the company scheduled to present at that event shortly after the RBC conference. This indicates a continued active presence in major healthcare industry forums throughout the second quarter of 2026.

RBC Capital Markets hosts a diverse range of conferences annually across multiple sectors, including technology, energy, financial institutions, and industrials. The healthcare conference remains one of its flagship events, drawing participation from major pharmaceutical companies, medical device manufacturers, and healthcare service providers.

For Johnson & Johnson, such conferences provide a venue to update investors on corporate strategy, pipeline developments, and financial performance without the formal constraints of quarterly earnings calls or annual meetings. The events typically include executive presentations, one-on-one meetings with institutional investors, and participation in panel discussions.